<code id='E75FA237DE'></code><style id='E75FA237DE'></style>
    • <acronym id='E75FA237DE'></acronym>
      <center id='E75FA237DE'><center id='E75FA237DE'><tfoot id='E75FA237DE'></tfoot></center><abbr id='E75FA237DE'><dir id='E75FA237DE'><tfoot id='E75FA237DE'></tfoot><noframes id='E75FA237DE'>

    • <optgroup id='E75FA237DE'><strike id='E75FA237DE'><sup id='E75FA237DE'></sup></strike><code id='E75FA237DE'></code></optgroup>
        1. <b id='E75FA237DE'><label id='E75FA237DE'><select id='E75FA237DE'><dt id='E75FA237DE'><span id='E75FA237DE'></span></dt></select></label></b><u id='E75FA237DE'></u>
          <i id='E75FA237DE'><strike id='E75FA237DE'><tt id='E75FA237DE'><pre id='E75FA237DE'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:456
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Celiac disease study examines precisely how gluten triggers injury
          Celiac disease study examines precisely how gluten triggers injury

          AmicrographofCeliacdiseaseNephron/WikimediaCommonsForapersonwithceliacdisease,eatingabagelgoessometh

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

          RubyWallauforSTATAbbViewillpay$10billionforthebiotechfirmImmunogen,thecompanysaidThursday,acquiringa